Article
Tasmanian devil CD28 and CTLA4 capture CD80 and CD86 from adjacent cells
2020-06-12
Abstract excerpt
Immune checkpoint immunotherapy is a pillar of human oncology treatment with potential for non-human species. The first checkpoint immunotherapy approved for human cancers targeted the CTLA4 protein. CTLA4 can inhibit T cell activation by capturing and internalizing CD80 and CD86 from antigen presenting cells, a process called trans-endocytosis. Similarly, CD28 can capture CD80 and CD86 via trogocytosis and retain...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bd7a726f-ecdc-5abb-8732-e4acdb3248b9
- DOI
- 10.1101/2020.06.11.145789
